Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ITRM Stock Annual Income Statement. Download in Excel

Iterum Therapeutics plc logo

Iterum Therapeutics plc

Sector: Healthcare   

Industry: Biotechnology

1.77
 
USD
  
0.14
  
(8.59%)
Previous close: 1.63  Open: 1.71  Bid: 1.73  Ask: 1.75
52 week range    
0.81   
   2.50
Mkt Cap: 42 M  Avg Vol (90 Days): 2,501,808
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 22nd November 2024

Stock Rankings

40
Value
28
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

ITRM Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-132.3-106.5-32.55-8.4-3.63-2.96
Basic EPS total-132.3-106.5-32.55-8.4-3.63-2.96
Basic weighted shares outstanding582273.0967869.02 M11 M12 M13 M
Depreciation-136000.0152000.0161000.0391000.084000.031000.0
DepreciationAndAmortization-136000.0152000.0161000.0391000.084000.031000.0
Diluted EPS total-132.3-106.5-32.55-8.4-3.63-2.96
Diluted normalized net income/share-3.63-2.96
Diluted weighted shares outstanding582273.0967869.02 M11 M12 M13 M
GainOnSaleOfSecurity-2 M-61 M5 M11 M
GeneralAndAdministrativeExpense9 M11 M11 M14 M13 M7 M
Gross operating profit869000.037000.0
Income before tax-77 M-103 M-51 M-91 M-44 M-38 M
Income taxes472000.0444000.0743000.0705000.0301000.0613000.0
Interest income-426000.0-861000.0-15 M-6 M-2 M-1 M
InterestExpenseNonOperating15 M6 M2 M
MiscOtherSpecialCharges401000.0196000.0-2 M195000.0-17 M82000.0
Net income from total operations-77 M-103 M-52 M-92 M-44 M-38 M
NetIncomeCommonStockholders-77 M-103 M-52 M-92 M-44 M-38 M
NetIncomeContinuousOperations-77 M-103 M-52 M-92 M-45 M-38 M
NetNonOperatingInterestIncomeExpense-426000.0-861000.0-15 M-6 M-2 M-1 M
Operating income-77 M-102 M-32 M-25 M-30 M-47 M
Operating income before depreciation (EBITDA)-76 M-102 M-36 M-78 M-38 M-35 M
OperatingExpense77 M102 M32 M25 M30 M47 M
Other income net-401000.0-196000.04 M61 M12 M-11 M
OtherGandA9 M11 M11 M14 M13 M7 M
OtherOperatingExpenses-77 M-2 M-563000.025 M30 M47 M
Research & development expense69 M91 M21 M11 M18 M40 M
ResearchExpense69 M91 M21 M11 M18 M40 M
Revenue per share-360000.0362000.011 M4 M2 M2 M
Selling Gen & administrative expense9 M11 M11 M14 M13 M7 M
Total Income available for interest expense (EBIT)-77 M-103 M-36 M-85 M-42 M-36 M
Total common shares outstanding957829.0991264.012 M12 M13 M16 M
Total net income-77 M-103 M-52 M-92 M-44 M-38 M
Total ordinary shares23 M23 M23 M23 M23 M23 M
Total revenues869000.037000.0
TotalExpenses77 M102 M32 M25 M30 M47 M
TotalRevenue869000.037000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University